Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways.

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • SJ Oh - (Author)
  • HH Erb - , Department of Urology (Author)
  • A Hobisch - (Author)
  • FR Santer - (Author)
  • Z Culig - (Author)

Details

Original languageEnglish
JournalEndocrine-Related Cancer
Publication statusPublished - Jun 2012
Peer-reviewedYes

External IDs

PubMed 22383427
PubMed PMC3353237
Scopus 84862653140

Keywords

Sustainable Development Goals